RxDoctor Payments Data

Duangnapa Cuddy, DO

Vascular Surgery · Lewisburg, WVNPI 1053515429

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 76.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $2,174 and has fallen 83.3% since, to $364 in 2025. That places this record below the midpoint for vascular surgery clinicians in WV, where the typical reported total is $5,101.

$5,101in general payments, 2019–2025

Across 67 payments — averaging $76.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Inari Medical, Inc.$401
  • Cook Incorporated$254
  • Endologix LLC$135
  • Kerecis Limited$135
  • Angiodynamics, Inc.$90
  • plus $178 from 4 others

What the payments were for

  • Travel & lodging$2,86656%
  • Food & beverage$2,09741%
  • Education$1393%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,101 in reported general payments places this provider in the 50th percentile of 32 vascular surgery providers in West Virginia.

See all vascular surgery providers in West Virginia

Medicare billing

Part B allowed, 2024
$63,260
Medicare patients
298
Services billed
608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban53$60,155
EliquisApixaban28$20,289
Atorvastatin Calcium309$2,911
Ezetimibe45$1,911
ClopidogrelClopidogrel Bisulfate164$1,883
Cilostazol36$586
Rosuvastatin Calcium33$355
Simvastatin20$173

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lewisburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →